Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284.
MANNOSTAB® LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization.
It provides a natural, simple solution to the stability requirements of filtered or non-filtered wines.
• A natural constituent already present in wines, MANNOSTAB® LIQUIDE 200 perfectly conserves the quality of the wine.
• Involving no waste materials, no energy or water consumption, MANNOSTAB® LIQUIDE 200 is a responsible treatment which complies with new environmental constraints.